Polypharmacy with antipsychotic drugs in patients with schizophrenia: Trends in multiple health care systems

Abstract

A multisystem study revealed that antipsychotic use among patients with schizophrenia varied substantially among health care systems and that nearly one fifth of patients with schizophrenia or other psychotic disorders in most of the health care systems experienced antipsychotic polypharmacy.